Over the course of a year, they can lead to more than 10% weight loss for some patients
Exclusion of patients with diabetes limited generalizability
Quick Answer: Diabetes GLP-1s (Ozempic, Mounjaro, Trulicity) are covered in nearly all 50 state Medicaid programs with PA The SUSTAIN program (Ozempic), SURPASS program (Mounjaro), and AWARD trials (Trulicity) provide the clinical basis
Participants taking GLP-1RAs reported lower levels of emotional eating, suggesting they were less likely to eat in response to stress or negative emotions
[1] Gallbladder problems including gallstones and inflammation of the gallbladder have been reported with GLP-1 receptor agonists and may cause fatigue alongside right upper quadrant pain, fever or jaundice
Circulating T(Fh) cells, serological memory, and tissue compartmentalization shape human influenza-specific b cell immunity